Taxane-Based Neoadjuvant Chemotherapy Clinical Trials

1 actively recruiting trial

Also known as: Docetaxel-based chemotherapy regimen, Paclitaxel/cyclophosphamide neoadjuvant therapy

Pipeline

Phase 2: 1

Top Sponsors

Peking University People's Hospital1

Indications

ctDNA Monitoring1
High-risk Breast Cancer1
Breast Cancer Early Stage Breast Cancer (Stage 1-3)1
HER2-negative Breast Cancer1
Hormone Receptor Positive Breast Cancer1

Other1 trial

ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.